| |
|
|
A high-throughput protein array-based approach
Centre for Proteomic and Genomic Research
Here we present a novel discovery-oriented high-throughput approach to the screening of allergen reactivates in crude biological extracts is presented using seafood allergens as an example. The CPGR workflow permits the effective screening of hundreds of putative allergens in parallel using minute amounts of patient serum and constitutes a cost-efficient allergen-specific antibody screening method for a routine diagnostic setting.
|
Development of a High-Throughput Microarray for Evaluating CYP1A1 Induction
Rensselaer Polytechnic Institute
The aim of this study is to produce a vector capable of expressing green fluorescent protein (GFP) when exposed to a CYP1A1 inducer.
|
Bio-analytic silicon chips for the detection of developmentalneurotoxic effects of chemicals and drugs in the context of the European REACH program
University of Rostock, Bionas GmbH
Bio-analytic silicon chips can be used to investigate stem cell differentiation into neurons and for the in vitro on-line monitoring of cellular reactions under well controlled experimental conditions. Chip systems allow for a parallel, label-free and non-invasive measurement of different parameters by CMOS silicon microsensors by the application of potential neurotoxic and developmental neurotoxic substances.
|
|
|
|
|
|
Permanent Senior Scientist Position in NMR-based Metabolomics
CIBERDEM
Tarragona, Spain
|
|
|
BBSRC Funded Microfluidics Engineering Resarch PhD
University College London
London, UK
|
|
|
Post-Doctpral Position in Mollusk Health Laboratory
UPEI
Charlottetown, Canada
|
|
|
Production Chemist II
Independent
Torrance, CA, USA
|
|
|
Research Chemist
Independent
Torrance, CA, USA
|
|
|
phD Scholarship in BioInformatics
Universitat Rovira i Virgili
Tarragona, Spain
|
|
|
QC Analyst
Genomic Health
Redwood City, CA, USA
|
|
|
Research Scientist II - Biology
Gilead Sciences
Foster City, CA, USA
|
|
|
|
Personalised Medicine, London, UK
22 May 2008 - 23 May 2008
Optimising the efficiency of your R&D strategy through effective investment into the tailored and personalised medicine arena.
|
Virtual Discovery Europe, Amsterdam, The Netherlands
19 June 2008 - 20 June 2008
This is the second annual Virtual Discovery Europe conference and exhibition. This meeting will be focusing on computer-aided drug design and screening. Topics to be covered are Virtual Screening, Computational Chemistry, Lead Identification and Optimisation, New Algorithms and Technologies and Chemoinformatics. Confirmed speakers are Prof. Wolfgang Sippl from Martin Luther University and Prof. Maurizio Botta of the University of Siena.
|
IBC’s 3rd Annual Beyond Antibodies, La Jolla, CA, USA
28 July 2008 - 29 July 2008
IBC’s 3rd Annual Beyond Antibodies conference on July 28-29, 2008 in La Jolla, CA will discuss recent scientific as well as business developments antibody alternatives. Attend and review data from companies with antibody alternatives in clinical and preclinical stages.
|
|
|
|
|
|
|
Emerging Markets for Microfluidic Applications
Published May 2007
Drug discovery remains today the first microfluidics market. Microfluidics key advantage is to enable higher analysis throughput while decreasing analysis time and cost. Firstly used at the system level for liquid handling, microfluidics technology is also successfully integrated in cartridges for research applications.
|
MicroReaction Technology
Published February 2007
The report presents the industry status of microreaction market, with players, their business models, products but it also describes the applications of the technology and the status of involvement of the fine chemical and pharmaceutical industry in this technology.
|
Protein Microarrays: Technology Adoption & Utilization
Published September 2005
Based on a 39-question survey of scientists in the field of proteomics, this report provides suppliers with insights into the types of products required to support this research. In order to benchmark the current state of the market for protein arrays, this report details researchers' experimental parameters, current and future levels of sample throughput and choice of supplier.
|
|
|